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Transdermal drug delivery systems have become increasingly sophisticated over time. However, 
the greatest limitation for developing an effective drug delivery system is the highly impermeable 
outermost layer of the skin called the stratum corneum. Therefore, materials penetrating the skin 
must be of low molecular weight, and lipophilic. There are many techniques to safely pass the stratum 
corneum and one of the promising method of transdermal drug delivery is the use of micro and nano 
sized particles. The aim of this study was to develop three different micro and nano sized carriers 
to study their skin penetration and to judge their effectiveness within the skin. Polymeric micro/
nanocapsules carrying a fluorescent dye Nile Red, were prepared using poly(3-hydroxybutyrate-co-
3-hydroxyvalerate) (PHBV) (5 %mol. hydroxyvalerate). The in vivo transdermal permeation of PHBV 
micro/nanoparticles were studied using a mouse model. According to the particle size analysis with 
Master Sizer and Zeta Potential Measurement System, the PHBV micro/nanocapsules were 1.9 µm, 
426 nm and 166 nm in diameter. The particles were applied to healthy skin of the dorsal region of 
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BALB/c mice. Penetration of the particles was determined by GC-MS analysis of the skin for PHBV. 
Scanning electron microscope (SEM) imaging was used to study their morphology. GC-MS results 
showed that the capsules penetrated into the skin in relation with their particle size, despite the 
highly impermeable outer skin layer. However, histology cross-section revealed that uncompromised 
skin could not penetrate; the transport of the polymeric particle was clearly impeded by the stratum 
corneum. It was thus shown in this study that control of penetration depth, and therefore, the target 
size within into the skin is possible by varying the size of the drug carrying nanocapsules.
Keywords: transdermal drug delivery, micro/nanocapsules, polymeric carriers, in vivo drug 
permeation.
Introduction
Transdermal drug applications are frequently 
used because of the effectiveness of the localized 
treatment, low cost, relatively low side effects, 
maximum drug availability at the target site, 
and avoids systemic circulation. Many bioactive 
agents, however, do not have the necessary 
physicochemical properties for satisfactory 
efficacy when applied topically (Sloan et al., 
2006).
Transdermal skin treatment requires the 
absorption of drug through the skin into the 
body. One of the biggest challenges in developing 
an effective system is to transfer the drug 
through the tightly structured stratum corneum 
when the skin is not compromised (Yow et al., 
2009). There are basically three layers of skin 
that needs to be passed: epidermis, dermis and 
subcutaneous tissue. The epidermis is the outer 
layer and serves as a barrier between the body 
and the environment. The dermis, which gives 
the skin its mechanical strength, is the thickest 
structure of the skin and consists of collagen 
fibers and glycoprotein filaments embedded 
in amorphous connective tissue. Capillaries in 
the dermis constitute a vascular surface of 1- 2 
cm2 of skin surface and serve the exchange of 
substances between blood and skin (Gawkrodger 
et al., 2002). The outermost layer of skin (stratum 
corneum) consists of keratinized corneocytes and 
intercellular lipid rich domains. The lipid matrix 
and the corneocytes, together, create a barrier, 
which is broken by hair follicles and sweat glands 
(Prausnitz, Lagner, 2008). These components 
covered <1 % of the surface area are believed 
to serve as a route of entry for nanoparticles. 
Encapsulation of the drug in a carrier allows 
the drug diffusing into hair follicles where drug 
release can occur in the deeper layers of the skin 
(Arora et al., 2008).
For the drugs to be able to cross the skin, 
in other words, to have skin permeability they 
need to be lipophilic and of low molecular 
weight. When the bioactive agent is prone to 
enzymatic attack or simple hydrolysis, it must be 
protected until it reaches the target site through 
complexation being attached to or entrapped 
by a carrier, preferably small size. Such labile 
molecules include proteins, DNA and other 
genetic materials, and vaccines. An important 
approach in this direction is the use of nanoscale 
drug delivery systems. Nanoparticles were 
developed as an important strategy to deliver 
conventional drugs like antibiotics (Gursel et 
al., 2001), recombinant proteins (Jahanshahi 
et al., 2008), vaccines (Rieuxet al., 2006), 
nucleotides (Xia et al., 2009) and growth factors 
(Yilgor et al., 2010). The special advantage of 
nanoparticles is their ability to reach tissues 
that other controlled release depots cannot 
and to release their contents there rather than 
staying in the circulation and releasing their 
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content systemically. With the developments 
in nanotechnology and their introduction to the 
biomaterials field, various types of nanosized 
drug delivery systems such as nanocapsules, 
nanospheres, complexes, liposomes, dendrimers 
and emulsions were developed. Among 
these are the uses of nanosized drug carriers 
constructed from biodegradable polymers are 
also increasingly used because even if they 
penetrate untargeted tissues they do not stay 
long and disintegrate (Yin, Feng 2005; Hasirci 
et al.; 2007, Yilgor et al., 2010).
Polyhydroxyalkanoates (PHAs) are among 
the preferred natural polymers, because they 
are produced in variety compositions with 
different properties including degradation rate 
by bacteria as well as by transgenic organisms 
(Hasirci, Yucel, 2007). The versatility of the 
products is due to ease of changing of the carbon 
source, bacteria type and the growth conditions 
in the reactor. PHAs are linear, semicrystalline, 
thermoplastic, bioresorbable and biocompatible 
polymers of microbiological origin which have 
a certain degree of biodegradability in the 
body (Amass et al, 1998; Sudesh et al., 2000; 
Martin, Williams, 2003; Volova et al., 2003; 
Volova 2004; Volova et al., 2006; Hasirci et al., 
2006) and as such have the advantage over the 
other polyester group, polylactides, which are 
petroleum based. The most abundantly tested 
PHA is poly(3-hydroxybutyrate) (P3HB) and 
its copolymers with 3-hydroxyvalerate, poly(3-
hydroxybutyrate-co-3-hydroxyvalerate) (PHBV), 
with varying proportions of HV. PHBV with 
various HV contents has been used in controlled 
release systems (anticancer agents, pain relievers, 
antibiotics, growth factors), biodegradable bone 
plates, and in tissue engineering (cornea, bone, 
cartilage) applications (Hasirci, Yucel, 2007; 
Goreva et al., 2012). 
In this study, in vivo transdermal permeation 
of PHBV micro/nanoparticles was studied by 
using Nile Red as a fluorescent agent to follow 
transdermal mobility of polymeric particles. The 
delivery system was constructed using PHBV 
micro/nanocapsules with different diameters, 
and whether the size of the particles influences 
the penetration depth was studied. The size 
distribution, morphology and skin penetration of 
the capsules were studied. Mouse skin was used 
for in vivo penetration studies and by histology 
examinations penetration depth of the particles 
were determined. 
Materials and Methods
Nile Red loaded PHBV  
capsule preparation
A solution of PHBV in dichloromethane 
(1.2 mL, 10 %, w/v) was prepared and then Nile 
Red (0.1 mL, 0.01 % in acetone) was added to this 
solution. An emulsion was formed by sonication 
for 15 s in an ice bath, added into a solution of 
PVA in distilled water (4 mL, 4 %, w/v) and 
sonicated again for 15 s. This emulsion (water/
oil/water) was further diluted with aqueous 
polyvinyl alcohol solution (PVA) (10 mL, 0.3 %, 
w/v), mixed with a magnetic stirrer overnight at 
room temperature for solvent evaporation. The 
capsules were precipitated by centrifugation and 
lyophilized.
Preparation of micro/nanocapsules  
with different sizes
In order to obtain different sized particles, 
different centrifuge speeds and durations were 
employed. To obtain low micron sized (largest) 
fraction, the suspension was centrifuged at 12000 
rpm (15455 g) for 10 min, in the centrifugation 
step of the preparation to recover the particles. 
The supernatant was further centrifuged at 13500 
rpm (18138 g) for 10 min to obtain high nano-sized 
particles. Finally, the remaining supernatant was 
centrifuged at 14500 rpm (22566 g) for 40 min to 
obtain the lowest diameter nanoparticles.
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Nanoparticle Topography  
with Scanning Electron Microscopy
An aqueous suspension of PHBV 
nanoparticles (100 µL, 1.2 %) was added onto 
carbon tapes (Electron Microscopy Sciences, 
USA) attached to SEM stubs, and Au-Pd sputter 
coating (2 nm) was performed under vacuum 
before the SEM study with QUANTA 400F Field 
Emission SEM (Netherlands). The diameters of 
the nanoparticles were measured from the SEM 
images using the Image J software (NIH).
Particle size distribution analysis
The size distribution of the micron sized 
PHBV particles were determined by Mastersizer 
(Malvern Instruments 2000, UK), meanwhile the 
nano sized PHBV particles were studied with the 
Zeta Potential and Mobility Measurement System 
(Malvern Nano ZS90, UK).
In vivo studies: preparation of PVA suspension 
containing PHBV micro/nanocapsules to 
enhance skin penetration
Two types of amphiphilic molecules, with 
low and high molecular weights, were tested as 
skin penetration enhancers, polyethyleneglycol 
(PEG) (MW 103) and PVA (MW 1.5х104). PEG 
and PVA were dissolved in distilled water at 
a concentration of 15 % (w/v) and 8 % (w/v), 
respectively. Solutions were heated to 50oC, 
filtered, and then 50 mg and 5 mg of Nile Red 
loaded PHBV capsules were suspended in 
these solutions to form 1 % (w/v) and 0.1 % 
(w/v) nanoparticle suspensions, respectively. 
Then, these suspensions were applied to the 
dorsal skin of the mice that was shaved one day 
earlier. 
In vivo studies: animal model
Experiments were conducted on male, 14 
week old, BALB/c mice (20-25 mg each). They 
were kept in an animal house in cages, two 
animals per cage, fed a standard laboratory diet 
and water in accordance with the Directives on 
Maintenance of Animals and Experimentation of 
Russian Federation (Genin et al., 2001). They were 
kept under standard environmental conditions. 
The in vivo experimental protocol was approved 
by the Institutional Animal Ethical Committee on 
Biomedical Ethics of Siberian Federal University, 
Krasnoyarsk, Russia.
In vivo studies: treatment of mice and 
application of polymeric particles
Dorsal sections of the mice were shaved 
before application of the formulations prepared 
as above desribed. After removal of the hair, skin 
was swabbed with pure ethanol to sterilize and 
dry the skin (Goope et al., 2009).
On the dorsal left side of the mice (12 
individuals), low concentration (0.5 mg/mL), and 
on the right side, high concentration (5 mg/mL) 
particle suspension (ca. 1 mL/day) was applied 
daily for 10 days. In total, 5 mg nanocapsules 
were applied to the left side and 50 mg to the right 
side of the mice.
Aliquots (200 μL) of micro and nanocapsule 
suspension were applied to the shaved skin 
followed by a 2 min massage using a cosmetic 
applicator. This application was repeated 
everyday for 10 days. The control was the 
intact skin of the mice. Controls were treated 
exactly same way, except the application of the 
formulation.
After 10 days, the animals were sacrificed 
with an overdose of formalin vapor. Skin patches 
(approximately 1x1 cm2) were removed and used 
in the determination of the polymer content, and 
thus, the amount of particles penetrated.
Determination of the polymer of the 
nanocapsules in the skin with GC-MS
The skin samples were dried at 60oC 
overnight and weighed. Then approximately 
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10 mg of sample was weighed and the polymer 
amount was determined with GC-MS.
To determine the polymer amount of 
the particles, approximately 4 mg of PHBV 
powder or its nanoparticles was refluxed in a 
solution of chloroform, methanol and sulfuric 
acid (1:0.85:0.15, v/v) for 140 min at 100oC in a 
thermostatically regulated bath. This method is 
called methanolysis, and degrades the polymer to 
its constituent, fatty acid methyl esters (FAME). 
After the digestion, distilled water (0.5 mL) 
was added and the tube was shaken for 1 min. 
After phase separation, the organic phase was 
transferred into a vial and analyzed in a gas 
chromatograph-mass spectrometer (GCD Plus, 
Hewlett Packard, USA), equipped with a 30 m x 
0.25 mm HP-5 capillary column (Sevastianov et 
al., 2003).
Histological preparation studies
The tissue samples were fixed in 10 % 
formalin and paraffin-embedded. The microtome 
sections (5µm) were obtained using microtome 
and stained with hematoxylin and eosin 
and examined under a light microscope (on 
fluorescence) (Leica DM6000B, Germany). This 
analysis was qualitative and analyzed either the 
presence or absence of polymer penetration. The 
general tissue reaction to micro and nanocapsules 
was investigated using conventional histological 
techniques.
Statistical analysis
All in vivo tests were carried out in 
duplicates. Statistical analysis of the results was 
made using the standard software of Microsoft 
Excel. Means and standard deviations were 
calculated. Significant differences between the 
mean values in control and test groups were 
determined using Student’s t-test. Means were 
considered to be significantly different for 
p≤ 0.05.
Results and Discussion 
Micro/nanocapsule characterization
Production of PHBV particles were 
carried out with 10 % (w/v) polymer solution in 
dichloromethane. The choice of this concentration 
was based on previous studies conducted with 
similar polymers (Chen et al., 2009; Yilgor et 
al., 2010). SEM micrographs show that round, 
spherical capsules with smooth surfaces and were 
obtained with 10 % (w/v) polymer solutions (Fig. 1). 
The change in the particle size could be controlled 
by changing the preparation parameters, such as 
the sonication time and speed (Xiong et al., 2010), 
centrifugation speed, surfactant concentration, 
and polymer concentration (Crowley et al., 2000; 
Ericco et al., 2009; Yilgor et al., 2010). In this study 
fractionation using successive centrifugations 
was employed. 
Three different capsule populations 
with different sizes were obtained. The SEM 
micrographs revealed that by changing the 
parameters of time and speed of centrifugation, 
it was possible to fractionate the particles into 
groups with different sizes (Table 1, Fig.1). The 
largest (1900 nm) particles were obtained in the 
first fractionation step (10 min, 12000 rpm). The 
medium sized particles (426 nm) were obtained 
after the second step (10 min, 13500 rpm) as 
seen in the Fig. 1a and 1b. The smallest PHBV 
particles (186 nm) were obtained after the third 
centrifugation (40 min, 14500 rpm) (Fig. 1c). 
SEM micrographs also show that all particles 
were round and spherical with smooth surfaces.
The samples are referred to as micro, nano 
and low nano, based on their average particle 
size, size range and polydispersity. Size range of 
the particles was determined by the Master Sizer 
for the microcapsules and Zeta Sizer for the nano 
and low nanocapsules. Polydispersity indices 
(PI) of these micro, submicro and nanoparticles 
were found to be 0.8, 0.3 and 0.1, respectively, 
indicating that the smallest fraction had the most 
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Fig. 1. SEM micrographs of PHBV particles prepared with different duration and speed of centrifugation: a) 10 
min at 12000 rpm. Bar 4 μm, b) 10 min at 13500 rpm. Bar 3 μm, c) 40 min at 14500 rpm. Bar 5 μm
Table 1. Sizes and polydispersity indices of PHBV micro/nanocapsules
Property
Sample
Micro Nano Low Nano
Mean Diameter, nm 1900 426 166
PI 0.8 0.3 0.1
Size Range, nm 400-12000 190-712 80-542
narrow particle size distribution as confirmed by 
the sharpness of the peak in Fig. 2c and the size 
range in Table 1. 
In vivo tests: penetration of micro/nanocapsules 
into mouse skin 
Transdermal delivery systems are being 
increasingly used in the clinic for delivery of small 
lipophilic drugs for low doses (Wermeling et al., 
2008; Baroli, 2010). The question being addressed 
in this study was whether the penetration depth 
of different sized particles in healthy skin differs. 
Therefore, the penetration of Nile Red stained 
PHBV micro/nanocapsules present as emulsions 
containing simple penetration enhancers (PEG 
and PVA) was studied on mouse skin. 
Upon sacrifice of mice, skin patches were 
removed, treated according to the section 2.5.2, 
and the amount of micro/nanoparticles in the skin 
was determined using GC-MS spectroscopy with 
0.05 mg of benzoic acid serving as a standard. 
The results of the analysis are shown in Table 2. 
It is apparent that particles penetrated into the 
skin at different rates, when different chemical 
enhancers were used. 
GC-MS results indicate that PHBV capsules 
penetrated into the skin to different extents 
(percent of the applied amount) depending on 
the chemical enhancer type used and on size 
(Table 2). Application of PVA solution (8 %) led 
to a 3-fold higher penetration of the same particles 
than PEG (15 %) did. For large particles (micro) 
penetration was calculated as 0.10 % and was 
lower than the nano and low nano sized particles, 
penetration of which were 50 % higher (0.15 % 
and 0.14 %, respectively), indicating that smaller 
particles penetrated the skin more effectively. 
After enhancement with PEG solution, however, 
the values were too low and very similar. It is 
probably the sensitivity of the analysis that could 
Fig. 2. Particle size distribution of PHBV particles. a) micron, b) submicron, c) nano sized samples
Table 2. PHBV micro/nanocapsule penetration into mice skin. High dose, 50 mg total, 5 mg/mL, application 
(n=2)
PHBV Capsule Type Enhancer Type Polymer Penetrated (mg/test area)
Polymer Penetration 












Low Nano 0.011 0.04±0.02
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not differentiate the differences if there were 
any.
PEG is a commonly used enhancer, 
especially effective when it is prepared in high 
concentrations as was applied in the present study 
(Heuschkel et al., 2008). But in this study PVA 
performed much better, and therefore, further 
tests involving the low dose application were 
conducted using PVA.
The low concentration of the particles 
applied to skin was found to be more effective; 
a higher fraction of the particles penetrated the 
skin and the size effect was much more distinct 
(Table 3). The area of the skin was equal in volume 
for high and low concentration carriers and the 
amount of penetrated polymers were relatively 
high with respect to high concentrated polymer 
suspension. It is not clear why low concentration 
got transferred more effectively, except may be 
the higher concentration particles clogged the 
channels at the hair follicles and decreased the 
permeants. In brief, low concentration carrier and 
PVA as enhancer should be considered to be used 
in further in vivo studies.
Histopathological analysis  
of mouse skin
The depth of penetration of three differently 
sized Nile Red loaded PHBV micro/nanocapsules 
was investigated by transdermal application in 
BALB/c mice using histopathology. Results of 
the histological examination of the skin of mice 
from experimental and control groups showed an 
identical morphological picture of the skin. No 
signs of necrosis or festering inflammation were 
observed in any group. Epidermis was of ordinary 
thickness, pilosebaceous units were fully formed, 
reaching a hypodermic-fatty layer. Follicles 
contained hair bars. Slight lymphohistiocytic 
infiltration was recorded perifollicularly (Fig. 3).
No significant differences were found in 
tissue response to implantation of three differently 
sized PHBV micro/nanocapsules used in this 
study; neither necrosis nor any other adverse 
morphological changes and tissue transformation 
in response to the application of the polymeric 
micro/nanocapsules were recorded. The results of 
the study suggest that PHBV is a good candidate 
for fabricating prolonged-action drugs in the form 
of micro/nanocapsules intended for transdermal 
application.
Conclusion
The aim of transdermal delivery systems is to 
deliver low molecular weight agents with the right set 
of properties without irritating the stratum corneum 
and deeper tissue layers. Polymeric particles are 
promising tools for these delivery applications. 
They can be made in various sizes, from various 
materials, carry molecules of different chemistries, 
and be modified for targeting purposes. As such, 
they are indispensible drug carriers. Polymeric 
capsules were prepared in micro, submicro and 
nano sizes. Upon fraction nano sized particles 
have shown narrower size distribution and lower 
polydispersity index. In vivo testing with BALB/c 
mice of particle penetration revealed that smaller 
particles penetrated the skin more effectively. The 
low concentration of the particles applied to skin 
was found more effective. These results give us 
possibility to consider bacterial PHBV, produced in 
the laboratory HABS and cleaned with the author 
technique, Bioplastotan®, to develop systems for 
transdermal transport, based particles smaller 
than 50 nm, which is necessary for penetration 
through intact skin, so as use elaborated sizes of 
particles for the treatment of compromised skin. 
These results give us ground to consider the use 
of bacterial PHBV in the development of systems 
for transdermal transport, taking into account 
high biocompatibility and  feasibility of  varying 
the speed of biodegradation PHA carrier with 
the composition of monomers and methods for 
producing the particles.
Fig. 3. Histology of the skin sample in BALB/c mice after application PVA (8 %), low dose of Nile Red loaded 
PHBV nanocapsules. Size of nanocapsules: a – 166 nm, b – 426 nm, c – 1900 nm
Table 3. PHBV micro/nanocapsule penetration into mice skin. Low dose, 5 mg total, 0.5 mg/mL, application 
(n=2)
PHBV Capsule Type Enhancer Type Polymer Penetrated(mg/test area)
Polymer Penetration






Low Nano 0.067 1.76±0.09
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Проникновение частиц из поли(3-гидроксибутирата/ 
3-гидроксивалерата) в кожу
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Трансдермальные системы доставки лекарственных средств становятся всё более 
совершенными. Однако самым большим препятствием для разработки систем доставки 
лекарственных средств является наличие практически непроницаемого верхнего рогового 
слоя эпидермиса. Материалы, проникающие через кожу, должны иметь низкий молекулярный 
вес и быть липофильными. Существует много способов преодолеть барьер рогового слоя, и 
один из перспективных методов – использование микро- и наночастиц. Это исследование было 
направлено на разработку трёх различных микро- и наноразмерных носителей, изучение их 
проникновения в кожу и оценку их эффективности в коже. Были сконструированы полимерные 
микро/нанокапсулы из поли(3-гидроксибутирата/3-гидроксивалерата) (ПГБВ) (ГВ 5 мол. %) 
с флуоресцентным красителем Nile Red. Трансдермальное проникновение микро/нанокапсул 
из ПГБВ было изучено in vivo, на мышах. Согласно анализу размера частиц, проведённому 
с помощью анализатора Master Sizer и системы измерения дзета-потенциала, микро/
нанокапсулы имели диаметр 1,9 мкм, 426 нм и 166 нм. Частицы наносили на здоровую кожу 
спины мышей линии BALB/c. Чтобы оценить проникновение частиц, определяли присутствие 
ПГБВ на коже методом хромато-масс-спектрометрии. Морфология исследовалась с 
помощью растрового электронного микроскопа. Результаты хромато-масс-спектрометрии 
показали, что проникновение капсул через кожу зависело от размера частиц, несмотря на 
труднопроницаемый верхний слой кожи. Однако гистологический поперечный разрез показал, 
что частицы не могли проникнуть через неповреждённую кожу; роговой слой эпидермиса явно 
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препятствовал переносу полимерных частиц. Данное исследование продемонстрировало, что, 
изменяя размер наночастиц, несущих лекарственные средства, можно регулировать глубину 
проникновения частиц и, следовательно, осуществлять целевую доставку лекарственных 
средств.
Ключевые слова: трансдермальная доставка лекарственных средств, микро/нанокапсулы, 
полимерные носители, проникновение лекарственных средств in vivo.
